- Report
- January 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- January 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- November 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 190 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 181 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 189 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- August 2024
- 116 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more